RCM
WST icon

Raleigh Capital Management’s West Pharmaceutical WST Stock Holding History

Raleigh Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26K Buy
+9
New +$2.24K ﹤0.01% 508
2025
Q2 		– Sell
-3
Closed -$672 – 711
2025
Q1 		$672 Sell
3
-19
-86% -$5.24K ﹤0.01% 472
2024
Q4 		$7.21K Buy
22
+1
+5% +$315 ﹤0.01% 660
2024
Q3 		$6.3K Buy
21
+14
+200% +$4.29K ﹤0.01% 668
2024
Q2 		$2.31K Sell
7
-1
-13% -$353 ﹤0.01% 768
2024
Q1 		$3.17K Sell
8
-81
-91% -$30K ﹤0.01% 713
2023
Q4 		$31.4K Buy
89
+7
+9% +$2.48K 0.01% 351
2023
Q3 		$30.8K Buy
82
+2
+3% +$773 0.02% 320
2023
Q2 		$30.6K Buy
+80
New +$28.6K 0.02% 303

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return